Despite substantial advancements have been achieved in the identification of long noncoding RNA (lncRNA) molecules, many challenges still remain into their functional characterization. Loss-of-function approaches are needed to study oncogenic lncRNAs, which appear more difficult to knock down by RNA interference as compared to mRNAs. In this chapter, we present a protocol based on the use of a novel class of antisense oligonucleotides, named locked nucleic acid (LNA) GapmeRs, to inhibit the oncogenic lncRNA NEAT1 in multiple myeloma cells. Overall, this approach holds many advantages, including its possible independence from delivery reagents as well as the capability to knock down lncRNAs even in hard-to-transfect suspension cells, like hematopoietic cells.
In Vitro Silencing of lncRNAs Using LNA GapmeRs / E. Taiana, V. Favasuli, D. Ronchetti, E. Morelli, P. Tassone, G. Viglietto, N.C. Munshi, A. Neri, N. Amodio (METHODS IN MOLECULAR BIOLOGY). - In: Long Non-Coding RNAs in Cancer[s.l] : Springer, 2021. - ISBN 9781071615805. - pp. 157-166 [10.1007/978-1-0716-1581-2_10]
In Vitro Silencing of lncRNAs Using LNA GapmeRs
E. Taiana;V. Favasuli;D. Ronchetti;A. Neri;
2021
Abstract
Despite substantial advancements have been achieved in the identification of long noncoding RNA (lncRNA) molecules, many challenges still remain into their functional characterization. Loss-of-function approaches are needed to study oncogenic lncRNAs, which appear more difficult to knock down by RNA interference as compared to mRNAs. In this chapter, we present a protocol based on the use of a novel class of antisense oligonucleotides, named locked nucleic acid (LNA) GapmeRs, to inhibit the oncogenic lncRNA NEAT1 in multiple myeloma cells. Overall, this approach holds many advantages, including its possible independence from delivery reagents as well as the capability to knock down lncRNAs even in hard-to-transfect suspension cells, like hematopoietic cells.File | Dimensione | Formato | |
---|---|---|---|
Taiana_Methods Mol Biol_2021_Book.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
292.13 kB
Formato
Adobe PDF
|
292.13 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.